Glycohale Fb Synchrobreathe Inhaler

Glycohale Fb Synchrobreathe Inhaler is a triple combination respiratory medication designed for the management of chronic obstructive pulmonary disease (COPD) and moderate to severe asthma. This advanced formulation provides comprehensive control over airway inflammation, bronchospasm, and mucus buildup—ensuring better lung function and long-term respiratory health.

This medicine combines three active agents:

• Budesonide (200 MCG) – a corticosteroid that reduces inflammation and swelling in the airways.

• Formoterol (6 MCG) – a long-acting β2-agonist (LABA) that relaxes the muscles around the airways, making breathing easier.

• Glycopyrronium (12.5 MCG) – a long-acting muscarinic antagonist (LAMA) that prevents airway constriction and helps keep the air passages open for longer durations.

Together, these components work synergistically to improve airflow, reduce flare-ups, and enhance breathing comfort in patients suffering from chronic respiratory disorders.